Last Updated: 31-07-2025 | Format: PDF | Report ID:20241 | Author: Manisha C
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $2,670 Million |
| What is the projected market size by 2035? | $5,950 Million |
| What is the market CAGR from 2025 to 2035? | 8.3% |
| Which region dominates the market? | US (74%) |
| Which product/service type dominates the market? | Sandwich Assays (52%) |
| Which application leads the market? | Clinical Testing (58%) |
| Who are the major buyers? | Hospitals & Clinics (41%), Reference/Research Labs (25%) |
| What are the key market growth drivers? | Rising incidence of infectious diseases and chronic conditions necessitating rapid diagnostics is driving LFA market demand; Increasing preference for decentralized and point-of-care testing is pushing demand for LFAs |
| What are the major market challenges? | Ensuring assay consistency and accuracy across different batches and manufacturers remains a challenge; Managing competition from advanced molecular diagnostics and alternative rapid test methods |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? | Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Siemens Healthineers AG, bioMérieux SA, PerkinElmer Inc. (Revvity), Meridian Bioscience Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Hologic Inc., Eiken Chemical Co. Ltd., QIAGEN N.V., Others |
Europe Early Stage Cancer Market: by Type (Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others), Distribution Channels (Hospitals, Diagnostic Centers, Cancer Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others), Technology (PCR, Next-Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Flow Cytometry, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Oxidative Stress Assay Market: by Type (Consumables, Instruments, Services), Application (Research, Clinical Diagnostics, Drug Discovery, Food Testing, Environmental Testing, Others), Distribution Channels (Direct Tender, Retail Sales, Online Sales, Distributors, E-commerce, Others), Technology (ELISA, Chromatography, Flow Cytometry, Spectrophotometry, Chemiluminescence, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Hemato Oncology Testing Market: by Type (Assays and Kits, Services), Application (Leukemia, Lymphoma, Myeloma, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Others), Technology (PCR, NGS, IHC, FISH, Cytogenetics, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America HLA Typing Market Market: by Type (Molecular Assays, Non-Molecular Assays), Application (Transplantation, Research, Disease Diagnosis, Donor Screening, Drug Discovery, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Wholesalers, Hospital Pharmacies, Others), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, SSO-PCR, SSP-PCR, Non-Molecular Assays, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025